Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

JS Loh, WQ Mak, LKS Tan, CX Ng, HH Chan… - … and Targeted Therapy, 2024 - nature.com
The human gastrointestinal tract is populated with a diverse microbial community. The vast
genetic and metabolic potential of the gut microbiome underpins its ubiquity in nearly every …

[HTML][HTML] Expanding the function of oligodendrocytes to brain energy metabolism

KA Nave, E Asadollahi, A Sasmita - Current Opinion in Neurobiology, 2023 - Elsevier
Oligodendrocytes are best known for wrapping myelin, a unique specialization that enables
energy-efficient and fast axonal impulse propagation in white matter tracts and fibers of the …

[HTML][HTML] Integrated multimodal cell atlas of Alzheimer's disease

MI Gabitto, KJ Travaglini, VM Rachleff, ES Kaplan… - Nature …, 2024 - nature.com
Alzheimer's disease (AD) is the leading cause of dementia in older adults. Although AD
progression is characterized by stereotyped accumulation of proteinopathies, the affected …

Oligodendrocytes produce amyloid-β and contribute to plaque formation alongside neurons in Alzheimer's disease model mice

AO Sasmita, C Depp, T Nazarenko, T Sun… - Nature …, 2024 - nature.com
Amyloid-β (Aβ) is thought to be neuronally derived in Alzheimer's disease (AD). However,
transcripts of amyloid precursor protein (APP) and amyloidogenic enzymes are equally …

T cell-mediated microglial activation triggers myelin pathology in a mouse model of amyloidosis

S Kedia, H Ji, R Feng, P Androvic, L Spieth, L Liu… - Nature …, 2024 - nature.com
Age-related myelin damage induces inflammatory responses, yet its involvement in
Alzheimer's disease remains uncertain, despite age being a major risk factor. Using a …

Inflammatory aspects of Alzheimer's disease

P Botella Lucena, MT Heneka - Acta Neuropathologica, 2024 - Springer
Alzheimer´ s disease (AD) stands out as the most common chronic neurodegenerative
disorder. AD is characterized by progressive cognitive decline and memory loss, with …

Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer's disease

RM Rajani, R Ellingford, M Hellmuth, SS Harris… - PLoS …, 2024 - journals.plos.org
Reduction of amyloid beta (Aβ) has been shown to be effective in treating Alzheimer's
disease (AD), but the underlying assumption that neurons are the main source of pathogenic …

Oxidative stress: a suitable therapeutic target for optic nerve diseases?

F Buonfiglio, EW Böhm, N Pfeiffer, A Gericke - Antioxidants, 2023 - mdpi.com
Optic nerve disorders encompass a wide spectrum of conditions characterized by the loss of
retinal ganglion cells (RGCs) and subsequent degeneration of the optic nerve. The etiology …

Updates in Alzheimer's disease: from basic research to diagnosis and therapies

E Liu, Y Zhang, JZ Wang - Translational Neurodegeneration, 2024 - Springer
Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized
pathologically by extracellular deposition of β-amyloid (Aβ) into senile plaques and …

[HTML][HTML] Single-cell multiplex chromatin and RNA interactions in ageing human brain

X Wen, Z Luo, W Zhao, R Calandrelli, TC Nguyen… - Nature, 2024 - nature.com
Dynamically organized chromatin complexes often involve multiplex chromatin interactions
and sometimes chromatin-associated RNA,–. Chromatin complex compositions change …